350 related articles for article (PubMed ID: 26321489)
21. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.
de Lissovoy G; Matza LS; Green H; Werner M; Edgar T
J Child Neurol; 2007 Jan; 22(1):49-59. PubMed ID: 17608306
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological interventions for spasticity following spinal cord injury: results of a Cochrane systematic review.
Taricco M; Pagliacci MC; Telaro E; Adone R
Eura Medicophys; 2006 Mar; 42(1):5-15. PubMed ID: 16565680
[TBL] [Abstract][Full Text] [Related]
23. Continuous intrathecal baclofen infusion for spasticity of cerebral origin.
Albright AL; Barron WB; Fasick MP; Polinko P; Janosky J
JAMA; 1993 Nov; 270(20):2475-7. PubMed ID: 8230625
[TBL] [Abstract][Full Text] [Related]
24. Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study.
Scheinberg A; Hall K; Lam LT; O'Flaherty S
J Paediatr Child Health; 2006 Nov; 42(11):715-20. PubMed ID: 17044900
[TBL] [Abstract][Full Text] [Related]
25. Continuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge?
Ramstad K; Jahnsen R; Lofterod B; Skjeldal OH
Acta Paediatr; 2010 Nov; 99(11):1661-5. PubMed ID: 19912148
[TBL] [Abstract][Full Text] [Related]
26. A controlled trial of baclofen in children with cerebral palsy.
Milla PJ; Jackson AD
J Int Med Res; 1977; 5(6):398-404. PubMed ID: 338390
[TBL] [Abstract][Full Text] [Related]
27. Intrathecal baclofen in cerebral palsy movement disorders.
Albright AL
J Child Neurol; 1996 Nov; 11 Suppl 1():S29-35. PubMed ID: 8959459
[TBL] [Abstract][Full Text] [Related]
28. Pharmacotherapy of spasticity: oral medications and intrathecal baclofen.
Krach LE
J Child Neurol; 2001 Jan; 16(1):31-6. PubMed ID: 11225954
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral Palsy.
McLaughlin MJ; He Y; Brunstrom-Hernandez J; Thio LL; Carleton BC; Ross CJD; Gaedigk A; Lewandowski A; Dai H; Jusko WJ; Leeder JS
PM R; 2018 Mar; 10(3):235-243. PubMed ID: 28867665
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a cost-effectiveness analysis.
Hoving MA; Evers SM; Ament AJ; van Raak EP; Vles JS;
Dev Med Child Neurol; 2008 Jun; 50(6):450-5. PubMed ID: 18422682
[TBL] [Abstract][Full Text] [Related]
31. Intrathecal baclofen infusion for ambulant children with cerebral palsy.
Brochard S; Remy-Neris O; Filipetti P; Bussel B
Pediatr Neurol; 2009 Apr; 40(4):265-70. PubMed ID: 19302938
[TBL] [Abstract][Full Text] [Related]
32. Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy.
Morton RE; Gray N; Vloeberghs M
Dev Med Child Neurol; 2011 Aug; 53(8):736-41. PubMed ID: 21707598
[TBL] [Abstract][Full Text] [Related]
33. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications.
Murphy NA; Irwin MC; Hoff C
Arch Phys Med Rehabil; 2002 Dec; 83(12):1721-5. PubMed ID: 12474176
[TBL] [Abstract][Full Text] [Related]
34. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy.
Buonaguro V; Scelsa B; Curci D; Monforte S; Iuorno T; Motta F
Pediatr Neurol; 2005 Aug; 33(2):110-3. PubMed ID: 16087055
[TBL] [Abstract][Full Text] [Related]
35. Surgical Tone Reduction in Cerebral Palsy.
Thomas SP; Addison AP; Curry DJ
Phys Med Rehabil Clin N Am; 2020 Feb; 31(1):91-105. PubMed ID: 31760996
[TBL] [Abstract][Full Text] [Related]
36. The effect of continuous intrathecal baclofen on sitting in children with severe cerebral palsy.
Gray N; Vloeberghs M
Eur J Paediatr Neurol; 2014 Jan; 18(1):45-9. PubMed ID: 24100173
[TBL] [Abstract][Full Text] [Related]
37. [Botulinum toxin type A in the treatment plan for cerebral palsy].
Strobl W
Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
39. Benefit of enteral baclofen in the management of spasticity in cerebral palsy.
Srinivasan R
J Pediatr Rehabil Med; 2023; 16(1):19-24. PubMed ID: 36938745
[No Abstract] [Full Text] [Related]
40. [Intrathecal baclofen for treatment of spasticity in patient with cerebral palsy--a preliminary report].
Jóźwiak M; Idzior M; Huber J; Szulc A; Grottel K
Chir Narzadow Ruchu Ortop Pol; 2003; 68(4):253-9. PubMed ID: 14702678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
